Medical Research and Clinical Trials

Unmasking a Master Regulator: Decades-Old Protein Revealed as Key Suppressor of Cancer Immunity

• Medical Research and Clinical Trials

Unmasking a Master Regulator: Decades-Old Protein Revealed as Key Suppressor of Cancer Immunity

Jia Lissa August 5, 2026

Stanford, CA – April 24, 2024 – In a discovery poised to fundamentally reshape our understanding of...

Read More Read more about Unmasking a Master Regulator: Decades-Old Protein Revealed as Key Suppressor of Cancer Immunity

New Hope for Breast Cancer Prevention: A Novel Alternative to Tamoxifen Emerges

• Medical Research and Clinical Trials

New Hope for Breast Cancer Prevention: A Novel Alternative to Tamoxifen Emerges

Nana August 4, 2026

A Critical Challenge in Women’s Health Breast cancer remains one of the most prevalent and devastating diseases...

Read More Read more about New Hope for Breast Cancer Prevention: A Novel Alternative to Tamoxifen Emerges

AI Breakthrough: UCLA Health Study Pioneers Earlier Detection of Interval Breast Cancers with Artificial Intelligence

• Medical Research and Clinical Trials

AI Breakthrough: UCLA Health Study Pioneers Earlier Detection of Interval Breast Cancers with Artificial Intelligence

Reynand Wu August 4, 2026

Los Angeles, CA – A groundbreaking study spearheaded by investigators at the UCLA Health Jonsson Comprehensive Cancer...

Read More Read more about AI Breakthrough: UCLA Health Study Pioneers Earlier Detection of Interval Breast Cancers with Artificial Intelligence

Rocket Pharmaceuticals Achieves Promising Safety Milestone in Danon Disease Gene Therapy Trial

• Medical Research and Clinical Trials

Rocket Pharmaceuticals Achieves Promising Safety Milestone in Danon Disease Gene Therapy Trial

Lina Hope August 4, 2026

San Francisco, CA – [Date of Publication] – Rocket Pharmaceuticals has announced a significant positive development in...

Read More Read more about Rocket Pharmaceuticals Achieves Promising Safety Milestone in Danon Disease Gene Therapy Trial

Promising Data Emerges for Annamycin in Relapsed/Refractory AML: MIRACLE Trial Shows Enhanced Remission Rates

• Medical Research and Clinical Trials

Promising Data Emerges for Annamycin in Relapsed/Refractory AML: MIRACLE Trial Shows Enhanced Remission Rates

Neng Nana August 4, 2026

New preliminary data from Moleculin Biotech’s pivotal Phase II/III MIRACLE trial has unveiled encouraging results for Annamycin...

Read More Read more about Promising Data Emerges for Annamycin in Relapsed/Refractory AML: MIRACLE Trial Shows Enhanced Remission Rates

AI and Human Radiologists: A Collaborative Future for Breast Cancer Screening, New Research Reveals

• Medical Research and Clinical Trials

AI and Human Radiologists: A Collaborative Future for Breast Cancer Screening, New Research Reveals

Layla Zulfa August 4, 2026

URBANA-CHAMPAIGN, IL – The future of breast cancer screening is not a battle between artificial intelligence and...

Read More Read more about AI and Human Radiologists: A Collaborative Future for Breast Cancer Screening, New Research Reveals

A Trojan Horse Against Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor’s Protectors

• Medical Research and Clinical Trials

A Trojan Horse Against Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor’s Protectors

Muslim August 3, 2026

NEW YORK, NY – In a significant stride against the relentless tide of metastatic cancer, scientists at...

Read More Read more about A Trojan Horse Against Cancer: Mount Sinai Scientists Redefine Immunotherapy by Targeting Tumor’s Protectors

Landmark Ruling: UK High Court Upholds Puberty Blocker Trial, Paving Way for Crucial Research

• Medical Research and Clinical Trials

Landmark Ruling: UK High Court Upholds Puberty Blocker Trial, Paving Way for Crucial Research

Iffa Jayyana August 3, 2026

London, UK – August 1, 2026 – In a significant decision that reverberated through the medical and...

Read More Read more about Landmark Ruling: UK High Court Upholds Puberty Blocker Trial, Paving Way for Crucial Research

Landmark Cambridge Study Unlocks Survival Benefits for BRCA Carriers with Breast Cancer, Challenging Long-Held Concerns

• Medical Research and Clinical Trials

Landmark Cambridge Study Unlocks Survival Benefits for BRCA Carriers with Breast Cancer, Challenging Long-Held Concerns

Neng Nana August 3, 2026

Cambridge, UK – A groundbreaking study by Cambridge researchers has delivered crucial insights for women diagnosed with...

Read More Read more about Landmark Cambridge Study Unlocks Survival Benefits for BRCA Carriers with Breast Cancer, Challenging Long-Held Concerns

Diakonos Oncology Initiates Landmark Phase I/II Trial for Refractory Melanoma with Promising Early Safety Profile

• Medical Research and Clinical Trials

Diakonos Oncology Initiates Landmark Phase I/II Trial for Refractory Melanoma with Promising Early Safety Profile

Evan Lee Salim August 3, 2026

California, USA & Alabama, USA – August 3, 2026 – Diakonos Oncology has marked a significant milestone...

Read More Read more about Diakonos Oncology Initiates Landmark Phase I/II Trial for Refractory Melanoma with Promising Early Safety Profile